Trevor represents issuers, investors and investment banks across various capital markets transactions, including initial public offerings (IPOs), follow-on public offerings, private investments in public equity (PIPEs), at-the-market (ATM) offerings and debt offerings. He regularly advises domestic and foreign life sciences companies regarding US Securities and Exchange Commission periodic reporting and disclosure obligations, annual meeting and proxy-related issues, beneficial ownership reporting, securities exchange listing standards, corporate governance, and Sarbanes-Oxley Act compliance, as well as other general corporate and securities matters. Trevor has also represented companies in connection with life sciences licensing transactions, reverse mergers, tender offers and other strategic transactions.
